Author
Listed:
- Martin Peifer
- Jonathan Weiss
- Martin L Sos
- Mirjam Koker
- Stefanie Heynck
- Christian Netzer
- Stefanie Fischer
- Haridas Rode
- Daniel Rauh
- Jörg Rahnenführer
- Roman K Thomas
Abstract
Despite the successful introduction of potent anti-cancer therapeutics, most of these drugs lead to only modest tumor-shrinkage or transient responses, followed by re-growth of tumors. Combining different compounds has resulted in enhanced tumor control and prolonged survival. However, methods querying the efficacy of such combinations have been hampered by limited scalability, analytical resolution, statistical feasibility, or a combination thereof. We have developed a theoretical framework modeling cellular viability as a stochastic lifetime process to determine synergistic compound combinations from high-throughput cellular screens. We apply our method to data derived from chemical perturbations of 65 cancer cell lines with two inhibitors. Our analysis revealed synergy for the combination of both compounds in subsets of cell lines. By contrast, in cell lines in which inhibition of one of both targets was sufficient to induce cell death, no synergy was detected, compatible with the topology of the oncogenically activated signaling network. In summary, we provide a tool for the measurement of synergy strength for combination perturbation experiments that might help define pathway topologies and direct clinical trials.
Suggested Citation
Martin Peifer & Jonathan Weiss & Martin L Sos & Mirjam Koker & Stefanie Heynck & Christian Netzer & Stefanie Fischer & Haridas Rode & Daniel Rauh & Jörg Rahnenführer & Roman K Thomas, 2010.
"Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling,"
PLOS ONE, Public Library of Science, vol. 5(1), pages 1-8, January.
Handle:
RePEc:plo:pone00:0008919
DOI: 10.1371/journal.pone.0008919
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0008919. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.